Teriflunomide in patients with multiple sclerosis
The article discusses the prospects for the use of the new drug teriflunomide for the treatment of patients with relapsing-remitting multiple sclerosis. By now, phase II and III clinical trials are completed which demonstrated good tolerability, efficacy and relative safety of teriflunomide. The TEM...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Russo |
| Baskı/Yayın Bilgisi: |
Remedium Group LLC
2015-12-01
|
| Seri Bilgileri: | Медицинский совет |
| Konular: | |
| Online Erişim: | https://www.med-sovet.pro/jour/article/view/177 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
